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Atrial septal defect in infancy:
To close or not to close?
To the Editor:
I read with great interest the article by
Lammers and associates1 advocating that
closure of an atrial septal defect (ASD)
should not be postponed to a later age if
clinical problems that can be attributed at
least in part to the ASD are present. How-
ever, a closer look at the historical cohort
of Lammers and associates reveals that it is
composed mainly of premature syndromic
infants in whom the major issue is bron-
chopulmonary dysplasia and pulmonary
hypertension rather than left-to-right shunt
across the ASD.2 Hence the suggestion of
the authors, in the opinion of this reader, is
controversial.
Although ASD is the second most com-
mon congenital heart disease in children,3
there are still few unanswered questions
related to the appropriate timing of closure.
Because patients with even large ASDs are
mostly asymptomatic, closure is recom-
mended around 3 to 5 years of age, before
the child goes to school. Postponing surgi-
cal intervention to this age also allows for
spontaneous closure of the ASD in some
children.4 In fact, there does not appear to
be any significant benefit in ASD closure
before 3 to 5 years of age in small- to
moderate-sized defects.5
In the opinion of this reader, in the
present era of better ventilator equipment
and styles of ventilator management, along
with widespread use of corticosteroids pre-
natally and surfactant, nitric oxide, and pul-
monary vasodilator therapy postnatally,
surgical ASD closure can be postponed in
patients with compromised lung function
unless all available means of improving
lung function have been tried. Only when
pulmonary compromising factors have
been corrected will an attempt at surgical
ASD closure in infancy be valid because
even though mortality for major operations
with cardiopulmonary bypass in infants
with low weight has become low, a definite
morbidity still persists.
Shahzad G. Raja, MRCS
Department of Cardiac Surgery
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Reply to the Editor:
We appreciate Dr Raja’s interest in our
recent study.1
We agree that in asymptomatic children
closure of an isolated secundum-type atrial
septal defect (ASD II) should be under-
taken after 4 to 5 years of age because this
might allow for spontaneous closure and
facilitate interventional closure in some pa-
tients. However, we describe a specific
group of patients in whom symptoms have
been at least in part related to the presence
of an ASD II. In these patients with com-
promised lungs and rarefied pulmonary
vasculature, even a minor left-to-right
shunt is poorly tolerated, and early surgical
closure could be beneficial.
Our catheter data showed that the ma-
jority of the children had a left-to-right
shunt that varied in magnitude, as is dem-
onstrated by the Qp/Qs ratio. The actual
effect of the left-to-right shunt on the in-
fant’s clinical condition is difficult to as-
sess. However, the ASD is an additional
factor compromising the child’s situation.
One cannot treat lung hypoplasia or severe
chronic lung disease, but an ASD is ame-
nable to treatment.
There might be a subgroup of patients
in whom closure of an ASD is contraindi-
cated. In the presence of progressive pul-
monary vascular disease, the existence of
an ASD can improve survival.2
Dr Raja suggests that surgical ASD clo-
sure in infancy should only be performed
after all other compromising factors are
corrected. Yet even in the current era of
better ventilator management and use of
antenatal corticosteroids, nitric oxide, and
surfactant leading to improved survival of
infants, correction of the lung-compromising
factors is not always possible. Moreover,
long-term hospitalization and prolonged
ventilation of these children is associated
with substantial morbidity, including baro-
trauma, hospital-acquired infections, and
immobilization. Therefore we contend that
a subgroup of infants can indeed benefit
from early ASD closure. Careful patient
selection, however, remains a clinical chal-
lenge and requires a multidisciplinary ap-
proach involving cardiologists, intensivists,
and cardiothoracic surgeons to determine
the right timing of ASD closure for each
individual child.
Astrid Lammers
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The evaluation of aortic
atherosclerosis and distensibility in
aortic valve stenosis—The role of
transesophageal echocardiography
To the Editor:
We read with great interest and congratulate
Weisenberg and associates on their trans-
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